Agoracom: Small Cap Investment - Pluristem Life Systems, Inc. - PSTI Pluristem Therapeutics announces Phase 1 trial to study PLX-PAD cells at th

patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Reply New Message

Back To Forum List View

emma

Rank: Treasurer [?]

Points: 16214 [?]

Votes: 82 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

PSTI Pluristem Therapeutics announces Phase 1 trial to study PLX-PAD cells at th

posted on May 08, 2013 08:46AM

PSTI	Pluristem Therapeutics announces Phase 1 trial to study PLX-PAD cells at theflyonthewall.com07:12am EDT

2 Recommendations

Reply New Message

Back To Forum List View

Please to post a reply